FEEDBACK
PLEASE WAIT ...
CLOSE
CLOSE

Country

Industries

  • Medicine ‎9
    • Pharmaceuticals ‎9

Location

AstraZeneca AB

  • 9Product
  • 1Types
  • 1Industry
Medicine
Products 9
Types 1

About Company

AstraZeneca is one of only a handful of pure-play biopharmaceutical companies to span the entire value chain of a medicine from discovery, early- and late-stage development to manufacturing and distribution, and the global commercialisation of primary care, specialty care-led and specialty care medicines that transform lives. Our primary focus is on three important areas of healthcare: Cardiovascular and Metabolic disease (CVMD); Oncology; and Respiratory,
AstraZeneca is one of only a handful of pure-play biopharmaceutical companies to span the entire value chain of a medicine from discovery, early- and late-stage development to manufacturing and distribution, and the global commercialisation of primary care, specialty care-led and specialty care medicines that transform lives. Our primary focus is on three important areas of healthcare: Cardiovascular and Metabolic disease (CVMD); Oncology; and Respiratory, Inflammation and Autoimmunity (RIA). We are also active in the Infection, Neuroscience and Gastrointestinal (ING) disease areas.

Products

MEDICINE - PHARMACEUTICALS   |  PLATELET AGGREGATION INHIBITORS

BRILINTA

MEDICINE - PHARMACEUTICALS   |  PLATELET AGGREGATION INHIBITORS

BRILINTA

MEDICINE - PHARMACEUTICALS   |  PLATELET AGGREGATION INHIBITORS

BRILINTA

MEDICINE - PHARMACEUTICALS   |  PLATELET AGGREGATION INHIBITORS

BRILINTA

MEDICINE - PHARMACEUTICALS   |  PLATELET AGGREGATION INHIBITORS

BRILINTA

Analytical Reports